business
Rodman & Renshaw initiates Neurogene stock with buy on gene therapy
Rodman & Renshaw initiates Neurogene stock with buy on gene therapy
Read full story on Investing.com → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop